Current Role of Radiotherapy for Renal-Cell Carcinoma: Review

Natalia Dengina, Ilya Tsimafeyeu, Timur Mitin

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Surgery is the standard of care for patients with renal-cell carcinoma (RCC). Radiotherapy (RT) can decrease the risk of local recurrence after surgery and can lead to excellent outcomes in patients unfit for surgery. We reviewed clinical experience with various forms of RT, including conventional fractionated RT and intraoperative radiotherapy (IORT) as adjunct to surgery, hypofractionated high-dose stereotactic body radiotherapy (SBRT), and particle therapy in unresectable RCC. We discuss future directions for using RT in the treatment of RCC. We encourage clinicians to incorporate RT modalities in prospective clinical trials.

Original languageEnglish (US)
Pages (from-to)183-187
Number of pages5
JournalClinical Genitourinary Cancer
Issue number2
StatePublished - Apr 1 2017


  • Intraoperative radiotherapy
  • Particle therapy
  • Radioresistance
  • Radiosensitivity
  • Stereotactic body radiotherapy
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'Current Role of Radiotherapy for Renal-Cell Carcinoma: Review'. Together they form a unique fingerprint.

Cite this